Shiming He

406 total citations · 1 hit paper
10 papers, 252 citations indexed

About

Shiming He is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shiming He has authored 10 papers receiving a total of 252 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Oncology and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shiming He's work include Pancreatic and Hepatic Oncology Research (2 papers), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). Shiming He is often cited by papers focused on Pancreatic and Hepatic Oncology Research (2 papers), Cancer therapeutics and mechanisms (1 paper) and RNA modifications and cancer (1 paper). Shiming He collaborates with scholars based in China, United Kingdom and United States. Shiming He's co-authors include Yong‐Su Zhen, Jian Xu, Chunyan Zhao, Zhonghua Yu, Daoliang Lan, Xianrong Xiong, Li Zhu, Hongyu Tao, Cong Huang and Gang Song and has published in prestigious journals such as International Journal of Biological Macromolecules, Medicine and International Journal of Nanomedicine.

In The Last Decade

Shiming He

9 papers receiving 251 citations

Hit Papers

Advances and challenges in the treatment of esophageal ca... 2021 2026 2022 2024 2021 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shiming He China 6 138 74 71 70 61 10 252
Mingwen Huang China 10 142 1.0× 54 0.7× 87 1.2× 61 0.9× 74 1.2× 22 279
Masataka Shimonosono Japan 10 124 0.9× 77 1.0× 114 1.6× 67 1.0× 104 1.7× 29 286
Ambika Chamoli India 3 156 1.1× 44 0.6× 80 1.1× 34 0.5× 93 1.5× 6 319
Shangqian Wang China 7 130 0.9× 80 1.1× 79 1.1× 33 0.5× 84 1.4× 10 229
Tianlin He China 10 160 1.2× 50 0.7× 116 1.6× 50 0.7× 85 1.4× 23 312
Yoko Koh Japan 10 102 0.7× 85 1.1× 70 1.0× 70 1.0× 77 1.3× 25 228
Hordur M. Kolbeinsson United States 5 79 0.6× 54 0.7× 172 2.4× 46 0.7× 70 1.1× 14 271
Zehua Ma China 8 162 1.2× 102 1.4× 83 1.2× 35 0.5× 124 2.0× 13 311
Scott J. Dawsey United States 5 103 0.7× 99 1.3× 115 1.6× 100 1.4× 49 0.8× 15 268

Countries citing papers authored by Shiming He

Since Specialization
Citations

This map shows the geographic impact of Shiming He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shiming He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shiming He more than expected).

Fields of papers citing papers by Shiming He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shiming He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shiming He. The network helps show where Shiming He may publish in the future.

Co-authorship network of co-authors of Shiming He

This figure shows the co-authorship network connecting the top 25 collaborators of Shiming He. A scholar is included among the top collaborators of Shiming He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shiming He. Shiming He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Rui, Rui, Cong Huang, Yucai Wu, et al.. (2025). Metallothionein 1X is a tumor suppressor gene and inhibits oxidative stress and metastasis in renal cell carcinoma. Discover Oncology. 16(1). 1545–1545.
2.
Li, Yuting, et al.. (2024). Aptamer-mediated therapeutic strategies provide a potential approach for cancer. International Immunopharmacology. 136. 112356–112356. 4 indexed citations
3.
He, Shiming, Bao Guan, Jian Fan, et al.. (2024). YWHAG promotes bladder cancer metastasis by regulating TMOD3 to activate ERK1/2 and JNK phosphorylation in the MAPK pathway. Journal of Translational Medicine. 22(1). 1159–1159. 1 indexed citations
4.
He, Shiming, et al.. (2023). Advances and Prospects in the Treatment of Pancreatic Cancer. International Journal of Nanomedicine. Volume 18. 3973–3988. 35 indexed citations
5.
Tao, Hongyu, et al.. (2022). Antitumor efficacy of a recombinant EGFR-targeted fusion protein conjugate that induces telomere shortening and telomerase downregulation. International Journal of Biological Macromolecules. 226. 1088–1099. 5 indexed citations
7.
He, Shiming, et al.. (2021). Advances and challenges in the treatment of esophageal cancer. Acta Pharmaceutica Sinica B. 11(11). 3379–3392. 174 indexed citations breakdown →
8.
Fu, Chao, et al.. (2021). Prognostic value of serum pentraxin 3 for intracerebral hemorrhage mortality. Journal of Integrative Neuroscience. 20(1). 137–142. 1 indexed citations
9.
He, Shiming, et al.. (2020). Transcriptomic study of yak mammary gland tissue during lactation. Animal Biotechnology. 33(4). 672–679. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026